These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9822098)

  • 1. Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure.
    Hülsmann M; Stanek B; Frey B; Sturm B; Putz D; Kos T; Berger R; Woloszczuk W; Putz D; Kos T; Berger R; Woloszczuk W; Maurer G; Pacher R
    J Am Coll Cardiol; 1998 Nov; 32(6):1695-700. PubMed ID: 9822098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.
    Pacher R; Stanek B; Hülsmann M; Koller-Strametz J; Berger R; Schuller M; Hartter E; Ogris E; Frey B; Heinz G; Maurer G
    J Am Coll Cardiol; 1996 Mar; 27(3):633-41. PubMed ID: 8606275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
    Stanek B; Frey B; Hülsmann M; Berger R; Sturm B; Strametz-Juranek J; Bergler-Klein J; Moser P; Bojic A; Hartter E; Pacher R
    J Am Coll Cardiol; 2001 Aug; 38(2):436-42. PubMed ID: 11499735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
    Isnard R; Pousset F; Trochu J; Chafirovskaïa O; Carayon A; Golmard J; Lechat P; Thomas D; Bouhour J; Komajda M
    Am J Cardiol; 2000 Aug; 86(4):417-21. PubMed ID: 10946035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
    Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B
    Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period.
    Berger R; Strecker K; Huelsmann M; Moser P; Frey B; Bojic A; Stanek B; Pacher R
    J Heart Lung Transplant; 2003 Sep; 22(9):1037-45. PubMed ID: 12957614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
    Masson S; Latini R; Anand IS; Barlera S; Judd D; Salio M; Perticone F; Perini G; Tognoni G; Cohn JN;
    J Card Fail; 2006 Jun; 12(5):375-80. PubMed ID: 16762801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental importance of peak-exercise plasma levels of endothelin-1 and natriuretic peptides in chronic heart failure.
    Yousufuddin M; Henein MY; Flather M; Wang D; Shamim W; O'Sullivan C; Kemp M; Kazzam E; Banner NR; Amrani M; Coats AJ
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):468-73. PubMed ID: 11486251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential big endothelin plasma levels in heart transplant recipients during bridging therapy and after successful heart transplantation.
    Strametz-Juranek J; Pacher R; Kos T; Woloszczuk W; Grimm M; Zuckermann A; Stanek B
    J Heart Lung Transplant; 2003 Jul; 22(7):731-7. PubMed ID: 12873540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big endothelin in chronic heart failure: marker of disease severity or genetic determination?
    Spinarová L; Spinar J; Vasků A; Goldbergová M; Ludka O; Toman J; Vítovec J; Tomandlová M; Tomandl J
    Int J Cardiol; 2004 Jan; 93(1):63-8. PubMed ID: 14729437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.
    Berger R; Huelsman M; Strecker K; Bojic A; Moser P; Stanek B; Pacher R
    Circulation; 2002 May; 105(20):2392-7. PubMed ID: 12021226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers influence the short-term and long-term prognostic information of natriuretic peptides and catecholamines in chronic heart failure independent from specific agents.
    Frankenstein L; Nelles M; Slavutsky M; Schellberg D; Doesch A; Katus H; Remppis A; Zugck C
    J Heart Lung Transplant; 2007 Oct; 26(10):1033-9. PubMed ID: 17919624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.
    Hülsmann M; Berger R; Sturm B; Bojic A; Woloszczuk W; Bergler-Klein J; Pacher R
    Eur Heart J; 2002 Jun; 23(11):886-91. PubMed ID: 12042010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaustive exercise-induced tissue hypoxia does not change endothelin and big endothelin plasma levels in normal volunteers.
    Lenz T; Nadansky M; Gossmann J; Oremek G; Geiger H
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):1028-31. PubMed ID: 9715798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy.
    Stelken AM; Younis LT; Jennison SH; Miller DD; Miller LW; Shaw LJ; Kargl D; Chaitman BR
    J Am Coll Cardiol; 1996 Feb; 27(2):345-52. PubMed ID: 8557904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.
    Di Salvo TG; Mathier M; Semigran MJ; Dec GW
    J Am Coll Cardiol; 1995 Apr; 25(5):1143-53. PubMed ID: 7897128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.